Venture Valuation together with KPMG and EuropaBio has published its most recent report at BIO in San Francisco in June 2016. The data for the cluster analysis is from Biotechgate (www.biotechgate.com), the global Biotech and Life Sciences database. According to the report, there are three types of European countries attractive to locate key value drivers of life science companies
- Countries with strong clusters of life science companies and an attractive tax and business environment
- Countries that have significant clusters of life science companies in their jurisdictions, but lack the benefits of an attractive business environment
- Countries which have attractive business and tax regimes without the support of a strong domestic biopharmaceutical industry
All three types of countries can offer appealing opportunities for hosting certain key value drivers of life science companies.